SUVEN PHARMACEUTICALS
|
The Current P/S Ratio of SUVEN PHARMACEUTICALS is 21.86.
Share Price | ₹866.4 | Oct 14,2025 |
Market Cap | ₹33,148.5 Cr | |
Sales-TTM | ₹1,516.2 Cr | TTM-Consolidated Results |
Price/Sales | 21.86x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹33,148.5 Cr] as on Oct 14,2025
(/) Sales [ ₹1,516.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 21.86x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '21.86 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS
PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 14.89x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 12.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 24.66x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 8.98x.
How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SUVEN PHARMACEUTICALS | 1,516.2 | 21.86 | 33,148.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.38 | 396,862.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 18.04 | 174,125.0 |
CIPLA LTD | 27,811.2 | 4.51 | 125,454.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.06 | 119,106.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.08 | 103,263.0 |
MANKIND PHARMA LTD | 12,956.2 | 7.76 | 100,546.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.17 | 98,525.4 |
LUPIN LTD | 23,375.9 | 3.79 | 88,506.5 |
AUROBINDO PHARMA LTD | 32,024.8 | 2.04 | 65,250.2 |
ABBOTT INDIA LTD | 6,589.9 | 9.71 | 63,967.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.04x |
Max industry PS | 21.86x |
Median industry PS | 7.38x |
Average industry PS | 8.40x |
You may also like the below Video Courses